OUR VISION:
Exact Sciences is committed to helping win the war on cancer through early detection.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

Exact Sciences announces appointment of John A. Fallon, M.D., to company's board of directors

MADISON, Wis., Jan. 25, 2016 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that John A. Fallon, M.D., has joined the company's board of directors. Dr. Fallon brings more than 40 years of experience in health management, reimbursement, primary care and academic medicine to the board. Most recently, Dr. Fallon served as chief physician executive and senior vice president...Read more

Wrapping Up a Successful 2016 JP Morgan Healthcare Conference Week

It's been a busy week at Exact Sciences.  On the heels of several important news releases Monday, the company attended the 2016 JP Morgan Healthcare Conference, sharing an update on the company as part of a presentation Thursday.  For further details, read on. Expanding Cologuard's In-Network Coverage Supports Continued Growth in 2016 The company's first release of the week...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com

FOR OUR INVESTORS

View updates on upcoming conference appearances, company news, financial reports and more.

Learn More